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Pulmonary nodulesAbstract Background: The accurate diagnosis of pleural effusion is challenging because even after
thoracocentesis and/or closed pleural biopsy, 25–40% of pleural effusion remains undiagnosed.
Thoracoscopy is now considered the approach of choice for diagnosis of certain kinds of pleural
diseases such as pleural mass, malignant pleural effusion with negative pleural ﬂuid cytology,
and in the diagnosis of pleural tuberculosis.
Aim of study: To evaluate the diagnostic utility and safety of medical thoracoscopy in patients
with undiagnosed exudative pleural effusion and pulmonary parenchyma lesions.
Methods: This study was conducted on 44 patients, 21 males and 23 females with age ranging
between 32 and 74 years (mean age 57.59 ± 7.1 years). There were 38 patients with undiagnosed
exudative pleural effusion, 3 patients with multiloculated pleural effusion, 1 patient with undiag-
nosed pulmonary nodules and 2 patients with undiagnosed pulmonary parenchyma ground glass
appearance and reticulation. There were 21 patients with co morbidities and 23 patients without
co morbidities.
Results: Forty four patients with undiagnosed pleural and pulmonary lesions underwent medical
thoracoscopy, multiple pleural nodules were found in 24 out of 44 patients (54.54%). Pleural mass
was found in 6 patients (13.63%) and pleural thickness was found in 8 patients (18.2%). Pleura loc-
ulation and adhesion was found in 3 patients (6.8%). Pulmonary nodules were found in 1 patient
(2.3%). Normal thoracoscopy was found in 2 patients (4.54%) and lung biopsy was taken. As
regards histopathology there were 16 patients (36.36%) diagnosed as epithelial mesothelioma, 3
patients (6.81%) diagnosed as metastatic squamous cell carcinoma, 1 patient (2.27%) diagnosed
as non Hodgkin lymphoma, and 4 patients diagnosed as tuberculosis. In patients with pleural mass
3 patients (6.81%) diagnosed as sarcomatous mesothelioma and 3 patients (6.81%) diagnosed as
non Hodgkin lymphoma. In 8 patients with pleural thickness, 6 patients (13.63%) diagnosed as
non speciﬁc pleurisy and 2 patients (4.54%) diagnosed as tuberculosis. In 3 patients with pleural
loculation they diagnosed as pleural ﬁbrosis. One patient with pulmonary nodules (2.27%) diag-
nosed as small cell carcinoma. In 2 patients with normal thoracoscopy lung biopsy showed desqua-
mative interstitial pneumonia in 1 patient (2.27%) and usual interstitial pneumonia in 1 patient
(2.27%). The diagnostic yield of medical thoracoscopy was 86.4% (38 patients with deﬁnite
histopathological diagnosis and 6 patients 13.6% diagnosed as non speciﬁc pleurisy). As regards
thoracoscopic complications bleeding needed blood transfusion occurred in 1 patient (2.27%) with
782 M.M. Elshamlymalignant mesothelioma, surgical emphysema occurred in 3 patients (1 with metastatic squamous
cell carcinoma, 1 with tuberculous pleural effusion and 1 with loculated empyema), hypotension
occurred in 1 patient underwent lung biopsy (desquamative interstitial pneumonia), the total tho-
racoscopic complications were 11.36% which was mild and statistically non signiﬁcant.
Conclusion: Medical thoracoscopy is safe and effective for the diagnosis of benign and malignant
pleural disease and pulmonary nodules.
 2016 The Egyptian Society of Chest Diseases and Tuberculosis. Production and hosting by Elsevier B.V.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-
nd/4.0/).Introduction
The accurate diagnosis of pleural effusion is challenging
because even after thoracocentesis and/or closed pleural
biopsy, 25–40% of pleural effusion remains undiagnosed
[1,2]. The most common causes of undiagnosed exudative pleu-
ral effusion are tuberculosis and malignancy. To ﬁnd out the
cause of pleural effusion, biochemical, cytological and microbi-
ological analysis of pleural ﬂuid is a common practice. It may
provide good diagnostic evidence for para-pneumonic effusion,
however this initial analysis cannot detect many cases of tuber-
culosis and malignancy. Pleural biopsy provides diagnostic evi-
dence for both tuberculosis and malignancy [3]. Thoracoscopy
is now considered the approach of choice for diagnosis of cer-
tain kinds of pleural diseases such as pleural mass, malignant
pleural effusion with negative pleural ﬂuid cytology, and in
the diagnosis of pleural tuberculosis [4]. Thoracoscopy offers
several advantages compared with thoracocentesis and closed
pleural biopsy, it potentially permits access to entire pleural
cavity including both the parietal and visceral pleura, allows
for directly visualized biopsies and affords control of bleeding
[5]. The diagnostic yield of thoracoscopy in malignant and
TB pleural effusion ranges from 91% to 94% and 93% to
100%, respectively. The traditional instrument used for thora-
coscopy has been the rigid thoracoscope. Medical thora-
coscopy with the rigid thoracoscope can be performed under
conscious sedation without the need for mechanical ventilation
[6]. Medical thoracoscopy can be used for therapeutic proce-
dures, such as adhesiolysis and evacuation of pleural ﬂuid in
patients with empyema, pleurodesis in patients with malignant
pleural effusion and spontaneous pneumothorax [7].
Patients and methods
This study was conducted in the Department of Pulmonary
Medicine at the Al-Hussien University Hospital, Al-Azhar
University, from June 2015 to May 2016. The study was
approved by the local institute ethics committee. All patients
underwent.
1. Detailed clinical evaluation with full history including age,
sex, smoking and asbestos exposure. History of systemic
hypertension, diabetes mellitus, cardiac disease, bleeding
disorders, previous anesthetic complications and any med-
ication history including anti-platelet/anticoagulant ther-
apy were obtained.
2. Symptomatic variable as dyspnea, chest pain, toxic syn-
drome that is deﬁned as presence of anorexia, weakness
and weight loss.3. General and local examination.
4. Sputum smears examinations for the presence of Acid-Fast
Bacilli (AFB) on three successive days.
5. Chest X-ray and computed tomography (CT).
6. Pleural ﬂuid aspiration and examination, for determination
of glucose, protein, lactate dehydrogenase, adenosine deam-
inase (ADA), culture and sensitivity for bacteria, fungi,
ziehl–Neelsen (Z–N) staining and cytological examination.
7. Closed pleural biopsy using Abram’s needle and
histopathological examination.
8. Bronchoscopy if there is any lung parenchyma lesion in CT
chest.
9. Complete blood count including prothrombin time (PT),
activated partial thromboplastin time (a PTT) and platelet
count to rule out bleeding diathesis.Indication of medical thoracoscopy
1. Undiagnosed pleural effusion: was deﬁned as failure to
achieve a diagnosis by initial pleural ﬂuid analysis including
pleural ﬂuid adenosine deaminase (ADA) levels, and pleu-
ral ﬂuid cytology and closed pleural biopsy negative for
malignant cells.
2. Loculated empyema.
3. Undiagnosed pleural or pulmonary nodules.Exclusion criteria
1. Patients with platelet count less than 75,000/mm3 and those
with PT or a PTT prolonged by more than four seconds
above control.
2. Hemodynamic instability or arrhythmias.
3. Uncorrected hypoxemia despite oxygen administration.
4. Patient who cannot withhold lateral decubitus position.
5. Intractable cough.Thoracoscopy procedure
1. Patients were kept fasting for six hours prior to the
procedure.
2. Vascular access was achieved with intravenous cannula
inserted in the upper limb opposite to the side of
thoracoscopy.
3. Bedside chest ultrasound for determination of accurate
entry port.
4. Determination of oxygen saturation.
5. We used single port for visualizing and taking pleural
biopsy.
Table 1 Demographic data and distribution of co morbidity
among the studied sample.
Parameter Number (percentage %)
Total number 44
Mean age/years 57.59 ± 7.1
Male 21 (47.7)
Mean age/years 55.71 ± 7.3
Female 23 (52.3)
Mean age/years 59.30 ± 6.5
Co morbidities 21 (47.7%)
1-Hypertension 7 (15.9%)
2-Diabetes mellitus 8 (18.18%)
3-Chronic bronchitis 3 (6.81%)
4-Bronchial asthma 2 (4.54%)
5-Splenectomy 1 (2.27%)
No co morbidity 23 (52.3%)
Safety of medical thoracoscopy 7836. Thoracoscopy was usually done under local or regional
anesthesia with spontaneous breathing and mild seda-
tion (midazolam 3–5 mg IV).
7. Patients were placed in lateral decubitus position with
the involved side upward.
8. After skin sterilization, local anesthesia, blunt dissection
was used to enter the pleural space between fourth and
sixth intercostals space along the mid axillary line.
9. Rigid thoracoscopy (KARL STORS) was inserted and
the pleural ﬂuid was drained by suction.
10. Pleural cavity, parietal, visceral and diaphragmatic pleu-
ral were inspected. Biopsies were performed under direct
visual control in all suspected areas, any bleeding was
controlled with electro-coagulation. Biopsies sent for
histopathological examination and immunohistochem-
istry when requested by pathologist.
11. In cases of loculated empyema, adhesions were gently
lyses using thoracoscopy or biopsy forceps to allow visu-
alization of pleural space and drainage of infected ﬂuid.
12. An intercostals tube was inserted before wound closure
to evacuate air and ﬂuid. Chest radiograph was per-
formed after thoracoscopy.Table 2 Relation between gender and type of lesion.
Type of lesion Total P
value1
Malignant Benign
Gender Males No 12 9 21 <0.001
% 27.3% 20.4% 47.7%
Females No 15 8 23
% 34.1% 18.2% 52.3%
Total No 27 17 44
% 61.4% 38.6% 100.0%
Bold value indicate signiﬁcance.
1 Fisher Exact test.Aim of the work
The aim of this study was to evaluate the diagnostic utility and
safety of medical thoracoscopy in patients with undiagnosed
exudative pleural effusion and pulmonary parenchyma lesion.
Statistical analysis of data
Statistical analysis was carried out using the SPSS computer
package version 17.0 (SPSS Inc., Chicago, IL, USA). The col-
lected data were statistically managed as follows:
– For descriptive statistics: the mean ± SD were used for
quantitative variables while the number and percentage
were used for qualitative variables.
– For analytic statistics: chi-square test was used to assess the
differences in frequency of qualitative variables, while Fis-
cher’s exact test (FET) was applied if any expected cell val-
ues in a 202 table was <5.
– In order to assess the differences in means of quantitative
variables between both groups, independent samples t-test
was applied.
– The statistical methods were veriﬁed, assuming a signiﬁcant
level of P< 0.05 and a highly signiﬁcant level of P< 0.001.
Results
This study was conducted on 44 patients, 21 males and 23
females with age ranging between 32 and 74 years (mean age
57.59 ± 7.1 years). There were 38 patients with undiagnosed
exudative pleural effusion, 3 patients with loculated effusion,
1 patient with undiagnosed pulmonary nodules and 2 patients
with undiagnosed pulmonary parenchyma ground glass
appearance and reticulation. There were 21 patients (47.7%)
with co morbidities, (7 hypertension, 8 diabetic, 3 chronic
bronchitis, 2 bronchial asthma, and 1 splenectomy) and 23
patients without co morbidities (Table 1).Table 2 shows the relation between gender and type of
lesion, malignant lesion was found in 27 out of 44 patients
(61.4%), it was more in females than in males with 47.7%
and 52.3% respectively and malignant lesion was more com-
mon than benign lesion with 61.4% and 38.6%, respectively,
the result was statistically signiﬁcant P< 0.001.
Table 3 shows the relation between co morbidities and type
of lesion, co morbidities was common in malignant lesion 19
out of 21 patients (90.4%) than in benign lesion in 2 out of
21 patients (9.6%), the difference was statistically signiﬁcant
P< 0.001.
Table 4 shows the clinical presentation, the main clinical
presentation was dyspnea in 44 patients 100%, chest pain in
19 patients 43.18%, cough in 26 patients 59.1%, expectoration
in 8 patients 18.2% and fever in 7 patients 15.9%.
Table 5 shows the relation between symptoms and type of
lesion, dyspnea was present in all patients with malignant
and benign lesion, chest pain present mainly in patients with
malignant lesion, 15 out of 44 patients (34.1%) versus 5 out
of 44 (11.36%) in patients with benign lesion, the difference
was statistically signiﬁcant P< 0.001. Cough was present
mainly in patients with malignant lesion 22 out of 44 patients
(50%) versus 4 out of 44 (9.1%) of patients with benign lesion,
the difference was statistically signiﬁcant P< 0.001. Expecto-
ration and fever was present only in benign lesion.
Table 6 shows the relation between sign and type of lesion,
right side dullness present in 19 out of 44 patients (43.2%) with
malignant lesion compared to 3 out of 44 patients (6.8%) with
Table 3 Relation between co morbidities and type of lesion.
Co morbidities Type of lesion Total P
value1
Malignant Benign
No co morbidity No 8 15 23 <0.001
% 18.2% 34.1% 52.3%
Hypertension No 7 0 7
% 15.9% 0.0% 15.9%
DM No 8 0 8
% 18.2% 0.0% 18.2%
Chronic
bronchitis
No 3 0 3
% 6.8% 0.0% 6.8%
Bronchial asthma No 1 1 2
% 2.3% 2.3% 4.5%
Splenectomy No 0 1 1
% 0.0% 2.3% 2.3%
Total No 27 17 44
% 61.4% 38.6% 100.0%
Bold value indicate signiﬁcance.
1 Chi square test.
Table 4 Clinical presentation.
Parameter No (percentage %)
Symptoms
1-Dyspnea 44 (100%)





2-Right side dullness 22 (50%)
3-Left side dullness 19 (43.18%)
4-Bilateral inspiratory crepitation 3 (6.8%)
Table 5 Relation between symptoms and type of lesion.
Clinical presentation Type of lesion Total P value1
Malignant Benign
Dyspnea No 27 17 44 –
% 61.4% 38.6% 100.0%
Chest pain No 15 4 19 <0.001
% 34.1% 9.1% 43.2%
Cough No 22 4 26 <0.001
% 50.0% 9.1% 59.1%
Expectoration No 0 8 8 0.016
% 0.0% 18.2% 18.2%
Fever No 0 7 7 0.032
% 0.0% 15.9% 15.9%
Total No 27 17 44
% 61.4% 38.6% 100.0%
Bold values indicate signiﬁcance.
1 Fisher Exact test.
Table 6 Relation between sign and type of lesion.





No 19 3 22 0.003
% 43.2% 6.8% 50.0%
Left side dullness
(pleural eﬀusion)
No 7 12 19
% 15.9% 27.3% 43.2%
Bilateral inspiratory
crepitations
No 1 2 3
% 2.3% 4.5% 6.8%
Total No 27 17 44
% 61.4% 38.6% 100.0%
Bold value indicate signiﬁcance.
1 Chi square test.
Table 7 Relation between chest X-ray ﬁnding and type of
lesion.





No 19 3 22 0.002
% 43.2% 6.8% 50.0%
Left side pleural
eﬀusion
No 7 12 19
% 15.9% 27.3% 43.2%
Bilateral pulmonary
nodules
No 1 0 1
% 2.3% 0.0% 2.3%
Bilateral ground
glass appearance
No 0 2 2
% 0.0% 4.5% 4.5%
Total No 27 17 44
% 61.4% 38.6% 100.0%
Bold value indicate signiﬁcance.
1 Chi square test.
784 M.M. Elshamlybenign lesion, left side dullness present in 7 out of 44 patients
(15.9%) with malignant lesion compared to 12 out of 44
patients (27.3%) with benign lesion, and inspiratory crepita-
tion present in 1 out of 44 patients (2.3%) with malignantlesion compared to 2 out of 44 patients (4.5%) with benign
lesion, the differences were statistically non signiﬁcant
P= 0.003.
Tables 7 and 8 show chest X-ray and chest computed
tomography ﬁnding, right side pleural effusion present in
(43.2%) of patients with malignant lesion compared to
(6.8%) in patients with benign lesion, left side pleural effusion
present in (27.3%) of patients with malignant lesion compared
to (15.5%) in patient with benign lesion, bilateral pulmonary
nodules with mediastinal and hilar lymph nodes enlargement
present in 2.3% of patient with malignant lesion compared
to 0.0% of patient with benign lesion and bilateral ground
glass appearance present in 4.5% in patients with benign lesion
compared to 0.0% in patient with malignant lesion, the differ-
ences was statistically non signiﬁcant.
Table 9 shows the relation between thoracoscopic ﬁnding
and type of lesion, multiple pleural nodules were found in 24
out of 44 patients (54.5%), (malignant lesion was found in
20 patients (45.5%), and benign lesion was found in 4 patients
(9.5%)). Pleural mass was found in 6 patients (13.6%) and all
were malignant lesions. Pleural thickness was found in 8
patients (18.2%) and all were benign lesions. Pleura loculation
and adhesion were found in 3 patients (6.8%) and all were
benign lesions. Pulmonary nodules were found in 1 patient
(2.3%) and it was a malignant lesion. Normal thoracoscopy
was found in 2 patients and lung biopsy showed benign lesions.
Table 9 Relation between thoracoscopic ﬁnding and type of
lesion.





No 20 4 24 0.002
% 45.5% 9.1% 54.5%
Pleural mass No 6 0 6 0.067
% 13.6% 0.0% 13.6%
Pleural thickness No 0 8 8 0.016
% 0.0% 18.2% 18.2%
Pleural loculation
and adhesion
No 0 3 3 0.272
% 0.0% 6.8% 6.8%
Pulmonary nodules No 1 0 1 0.272
% 2.3% 0.0% 2.27%
Normal
thoracoscopy
No 0 2 2 0.272
% 0.0% 4.54% 4.54%
Total No 27 17 44
% 61.4% 38.6% 100.0%
Bold values indicate signiﬁcance.
1 Fisher Exact test.









No 19 3 22 0.002
% 43.2% 6.8% 50.0%
Left side pleural
eﬀusion
No 7 12 19 1.000





No 1 0 1 0.272
% 2.3% 0.0% 2.3%
Bilateral ground
glass appearance
No 0 2 2 0.515
% 0.0% 4.5% 4.5%
Total No 27 17 44
% 61.4% 38.6% 100.0%
Bold value indicate signiﬁcance.
1 Fisher Exact test.
Safety of medical thoracoscopy 785Table 10 shows comparison between thoracoscopic ﬁnding
and histopathological types, in 24 patients with pleural nod-
ules, there were 16 patients (36.36%) diagnosed as epithelial
mesothelioma, 3 patients (6.81%) diagnosed as metastatic
squamous cell carcinoma, 1 patient (2.27%) diagnosed as
non Hodgkin lymphoma, and 4 patients diagnosed as tubercu-
losis. In patients with pleural mass 3 patients (6.81%) diag-
nosed as sarcomatous mesothelioma and 3 patients (6.81%)
diagnosed as non Hodgkin lymphoma. In 8 patients with pleu-
ral thickening, 6 patients (13.63%) diagnosed as non speciﬁc
pleurisy and 2 patients (4.54%) diagnosed as tuberculosis. In
3 patients with pleural loculation, diagnosed as pleural ﬁbrosis.
One patient with pulmonary nodules (2.27%) diagnosed as
small cell carcinoma. In 2 patients with normal thoracoscopy
lung biopsy showed desquamative interstitial pneumonia in 1
patient (2.27%) and usual interstitial pneumonia in 1 patient
(2.27%).Table 11 Shows thoracoscopic complications, bleeding
needed blood transfusion occurred in 1 patient (2.27%) with
malignant mesothelioma, surgical emphysema occurred in 3
patients (1 with metastatic squamous cell carcinoma, 1 with
tuberculous pleural effusion and 1 with loculated empyema),
hypotension occurred in 1 patient underwent lung biopsy
(desquamative interstitial pneumonia), the total thoracoscopic
complications were 11.36% which was statistically non signif-
icant P= 0.265 (Figs. 1–6).
Discussion
Medical thoracoscopy is a minimally invasive procedure that
allows complete visualization of the pleural space using a com-
bination of viewing and working instruments enabling the
diagnostic and the therapeutic procedures [8]. Thoracoscopy
is a safe and valuable tool for diagnosis of undiagnosed pleural
effusion, particularly for patients with high probability of
malignancy. Overall cost effectiveness of thoracoscopy is bet-
ter in view of its better yield and lesser duration of hospital
stay [9].
In this study there were 38 patients with undiagnosed
exudative pleural effusion, 3 patients with undiagnosed locu-
lated pleural effusion, 1 patient with undiagnosed pulmonary
nodules and 2 patients with undiagnosed pulmonary parench-
yma ground glass appearance and reticulation. There were 21
patients (47.7%) with co morbidities and 23 patients (52.3%)
without co morbidities. The main presenting symptoms were
dyspnea 100%, cough 59% and chest pain 43.18% which were
common in patients with malignant lesion, this ﬁndings in
agreement with study that was done by Hatata et al., they
found that the main presenting symptom was dyspnea
(100% of patients), while cough, chest pain and loss of weight
were observed in 60%, 20% and 26.7% of cases respectively
[10].
Chest X-ray and CT chest conﬁrmed the presence of pleural
effusion in 38 patients, loculated pleural effusion in 3 patients,
pulmonary nodules in 1 patient and pulmonary parenchyma
ground glass appearance and reticulation in 2 patients. Before
thoracoscopy portable chest ultrasound was done to localize
the optimal site of entry.
In this study the thoracoscopy showed that multiple pleural
nodules were found in 24 out of 44 patients (54.54%). Pleural
mass was found in 6 patients (13.6%). Pleural thickness was
found in 8 patients (18.2%). Pleura loculation and adhesion
(empyema) was found in 3 patients (6.8%). Pulmonary nod-
ules were found in 1 patient (2.3%). Normal thoracoscopy
was found in 2 patients. In all patients multiple biopsies were
taken to increase the diagnostic yield. As regard histopatholog-
ical diagnosis, in 24 patients with pleural nodules, there were
16 patients (36.36%) had epithelial mesothelioma, 3 patients
(6.81%) had metastatic squamous cell carcinoma, 1 patient
(2.27%) had non Hodgkin lymphoma and 4 patients diag-
nosed as tuberculosis. In patients with pleural mass 3 patients
(6.81%) diagnosed ad sarcomatous mesothelioma and 3
patients (6.81%) diagnosed as non Hodgkin lymphoma. In 8
patients with pleural thickening, 6 patients (13.63%) diag-
nosed as non speciﬁc pleurisy and 2 patients (4.54%) diag-
nosed as tuberculosis. In 3 patients with pleural loculation,
diagnosed as pleural ﬁbrosis. In 1 patient with pulmonary nod-
ules diagnosed as small cell carcinoma, in 2 patients with nor-
Table 10 Comparison between thoracoscopic ﬁnding and histopathological types.






Pleural lesion Pleural nodules 24
(54.54%)
– Epithelial mesothelioma 16 (36.36%)- 0 (0.0%) 16 (36.36%) <0.001
– Metastatic squamous cell carcinoma 3
(6.81%)
0 (0.0%) 3 (6.81%)
– Tuberculosis 4 (9%) 4 (9%) 0 (0.0%)
– Non Hodgkin lymphoma 1 (2.27%) 0 (0.0%) 1 (2.27%)
Pleural mass 6 (13.6%) – Sarcomatous mesothelioma 3 (6.81%) 0 (0.0%) 3 (6.81%)
– Non Hodgkin lymphoma 3 (6.81%) 0 (0.0%) 3 (6.81%)
Pleural thickening 8
(18.18%)
– Non speciﬁc pleurisy 6 (13.63%) 6 (13.63%) 0 (0.0%)
– Tuberculosis 2 (4.45%) 2 (4.54%) 0 (0.0%)
Pleural loculation 3
(6.81%)





Small cell carcinoma 1 (2.27%) 0 (0.0%) 1 (2.27%) -
Normal 2 (4.45%) – Desquamative interstitial pneumonia 1
(2.27%)
1 (2.27%) 0 (0.0%)
– Usual interstitial pneumonia 1 (2.27%) 1 (2.27%) 0 (0.0%)
Total 44 44 (100.0%) 17 (38.63%) 27 (61.36%)
Bold value indicate signiﬁcance.
1 Chi square test.
Table 11 Thoracoscopic complications.
Parameters No 44 (%) Histological type P value1
1-Bleeding need transfusion 1 (2.27%) – Malignant mesothelioma (epithelial type) 0.265
2-Surgical emphysema 1 (2.27%) – Metastatic squamous cell carcinoma
1 (2.27%) – Tuberculosis pleural effusion
1 (2.27%) – Loculated Empyema (pleural ﬁbrosis)
3-Hypotension 1 (2.27%) – Lung biopsy (desquamative interstitial pneumonia
Total 5 (11.36%)
1 Chi square test.
Figure 1 Chest X-ray of 34 male patient with loculated
empyema.
786 M.M. Elshamlymal thoracoscopy lung biopsy showed desquamative intersti-
tial pneumonia in 1 patient (2.27%) and usual interstitial pneu-
monia in 1 patient (2.27%).In my study all over, malignant lesion was present in 27
patients (61.4%) and benign lesion was present in 17 patients
(38.6%). The study conducted by Laila et al. [9] found the tho-
racoscopic ﬁndings in the studied group, in which nodules were
found in 28 patients (77%), 5 patients (12.5%) had sago grain
nodules, 3 patients (7.5%) had adhesions, one patient had col-
lection of pus, one patient (2.5%) had a mass, one patient
(2.5%) had Violaceous lesion, and one patient (2.5%) had nor-
mal pleura, also they found that the malignancy was diagnosed
in 28 patients (70%), malignant pleural mesothelioma was
diagnosed in 15 patients (53.6%), while metastatic pleural
malignancy found in 13 patients. Metastatic adenocarcinoma
was found in 10 patients (35.6%), non-Hodgkin lymphoma
was found in one patient (3.6%), mucoepidermoid carcinoma
was found in one patient (3.6%), and lastly Kaposi sarcoma
which was found in one patient (3.6%).
In the study which was done by Nattusamy et al. [11], out
of the 36 patients who were initially suspected to have malig-
nant pleural effusion on clinico-radiological basis, malignant
pleural involvement was conﬁrmed on histopathology in 30
patients. Non-speciﬁc pleurisy was diagnosed in ﬁve patients
and normal pleura in one patient. No patients were diagnosed
with tuberculosis (TB) in this group. Out of the 10 patients
with clinico-radiological suspicion of TB, 2 patients had
histopathologically conﬁrmed TB and remaining 8 patients
Figure 2 Chest ultrasound of the same patient showed multiple
loculated pleural effusion.
Figure 3 Thoracoscopy of the same patient showed multiple
loculation with adhesion.
Figure 4 Chest X-ray of the same patient after thoracoscopy and
cutting of pleural adhesion.
Figure 5 CT chest of 54 year old patient with bilateral pul-
monary nodules.
Safety of medical thoracoscopy 787had non-speciﬁc pleurisy. Of the two patients with empyema
who underwent semi-rigid thoracoscopy, one patient had nor-
mal pleura and the other had non-speciﬁc pleurisy on pleural
biopsy. Both these patients had remarkable improvement after
thoracoscopic adhesiolysis and guided chest tube drain place-
ment. In another study by Prabhu and Narasimha [12], a total
of 68 patients underwent pleuroscopy from September 2007 to
August 2010. Nodules were found in 33 patients, 26 patientshad adhesions, 8 patients had sago grain appearance, and 1
patient had normal pleura. Out of 68 patients, 24 patients
had malignancy, 16 patients had tuberculosis, 22 patients
had non-speciﬁc inﬂammation, 2 patients had empyema, 1
patient had sarcoidosis, 1 patient had normal pleura and it
was non-diagnostic in 2 patients. The diagnostic yield for a
pleuroscopic pleural biopsy was 97%. In 24 patients who
had malignancy, 15 patients had metastatic adenocarcinoma,
three patients had mesothelioma, three patients had undiffer-
entiated carcinoma, one patient had lymphoma, one patient
had metastatic clear cell carcinoma and one patient had meta-
static squamous cell carcinoma. In 22 patients who had no
speciﬁc inﬂammation eight patients had chronic inﬂammation,
seven patients had ﬁbrinous exudates, four patients had suba-
cute inﬂammation and three patients had lymphohistiocytic
inﬁltrates. There were no major complications, only four
Figure 6 Multiple pleural nodules in 65 year old female patient
with hemorrhagic pleural effusion.
788 M.M. Elshamlypatients had minor complications like subcutaneous emphy-
sema (3 patients) and prolonged air leak (1 patient).
In this study there were 3 cases of multiloculated empyema
with difﬁcult drainage due to adhesions, thoracoscopy with
performing mechanical adhesiolysis, cutting of septa and drai-
nage of pleural ﬂuid resulted in marked clinical and radiologi-
cal improvement in form of lung expansion. Wakabayashi [13]
described 20 patients who underwent debridement of chronic
empyema by thoracoscopy through a small incision, the lungs
reexpanded in 18 patients (90%). The lung failed to reexpand
in two patients, both of whom had empyema for more than
4 months duration. Ridley and Braimbridge [14] reported over-
all complete resolution of empyema in 18 of 30 (60%) selected
patients even though many were investigated at a late stage
after initial treatment regimens had failed. Of the 12 patients
who did not have complete resolution after thoracoscopy, the
empyema resolved in eight (66%) patients after open surgical
procedures. Thoracoscopic debridement may provide valuable
time to improve the clinical condition of debilitated patients
until they can tolerate more aggressive surgical approaches.
With thoracoscopy, the loculations in the pleural space can
be disrupted, the pleural space can be completely drained,
and the chest tube can be optimally placed [15]. Patients with
multiloculated thoracic empyema stratiﬁed by ultrasonography
and treated early by medical thoracoscopy show that this
approach is safe, minimally invasive, and efﬁcient in these
patients with a disease having relevant mortality [16].
In this study there were 3 patients with pulmonary parench-
yma lesion, one patient with multiple pulmonary nodules and
two patients with bilateral ground glass appearance, bron-
choscopy and transbronchial biopsy was taken without reach
histopathological diagnosis, thoracoscopic lung biopsy was
done with deﬁnite histopathological diagnosis in all three
cases. In the study done by Vansteenkiste et al., [17] they found
that medical thoracoscopy with lung biopsy is an effective and
safe procedure in the hands of well trained interventional
pulmonologists.
In study done by Molin et al. [18] they found that medical
thoracoscopic lung biopsy (MTLB) can be an interesting sec-
ond choice for interventional pulmonologists in a variety ofinterstitial lung diseases (ILD) if transbronchial lung biopsy
(TBB) or bronchoalveolar lavage (BAL) has failed to provide
a diagnosis. The technique has some advantages over a surgi-
cal biopsy, which can be reserved as the ﬁnal step in many
instances. The possibility to take several biopsies from differ-
ent sites under visual guidance, and the lower morbidity are
the most important advantages.
In this study histopathological diagnosis was malignant in
27 out of 44 patients (61.36%) and benign in 17 out of 44
patients (38.64%). The diagnostic yield of medical thora-
coscopy was 86.4% (38 patients with deﬁnite histopathological
diagnosis and 6 patients (13.6%) diagnosed as non speciﬁc
pleurisy. But if 6 patients diagnosed as non speciﬁc pleurisy
were included the diagnosis was deﬁnite in all patients
(100%) without a need for other procedures to conﬁrm the
diagnosis, so thoracoscopic forceps pleural and lung biopsy
in the diagnosis of different pleural and lung lesions as well
as therapeutic mechanical adhesiolysis in loculated empyema
are safe and efﬁcient. In the study done by Laila et al. [9], med-
ical thoracoscopy gave a deﬁnitive diagnosis in 38 out of 40
patients with a diagnostic yield of 95%. In another study by
Prabhu and Narasimhan [12] they found that the diagnostic
yield of thoracoscopy was 97%.
In this study as regards thoracoscopic complications, one
patient developed bleeding need blood transfusion (malignant
mesothelioma), three patients developed surgical emphysema
which may be related to size of the wound and tightness of the
sutures, and one patient developed hypotension. There is no
mortality and complications were statistically non signiﬁcant.
In comparison with other studies like in Menzies et al. [19],
Francois et al. [20], Munavvar et al. [21], and Law et al. [22],
overall complication rates for thoracoscopy are 1% to 5%; how-
ever, most are minor and do not prolong hospital stay. Compli-
cations include subcutaneous emphysema (0.6–5%), empyema
(2–3%), bleeding (0.4–2%), and reexpansion pulmonary edema
(2.2%). mortality rate of 0.8% has been published from large
centers performing pleuroscopy [23]. So medical thoracoscopy
is an extremely useful diagnostic modality that can often con-
tribute crucially to accurate clinical decision-making in patients
with undiagnosed pleural effusion [24,25].
Conclusion
Medical thoracoscopy is safe and effective for the diagnosis of
benign and malignant pleural disease and pulmonary nodules.
Medical thoracoscopy is preferable when performing adhesiol-
ysis in cases of loculated empyema.
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